Search

Recognizing International NASH Day


During International NASH Day 2019, Resoundant is proud to join the Global Liver Institute (GLI) and many other dedicated clinicians and patients in raising awareness of this life threatening condition.

Non-alcoholic steatohepatitis, or NASH, has been called an epidemic, a "ticking time bomb", and a "silent tsunami". It is the progressive form of non-alcoholic fatty liver disease (NAFLD), and affects more than 115 million people worldwide. An estimated 357 million people will be affected by 2030.

Because NASH symptoms are not overt, NASH is often underdiagnosed and underreported. NAFLD and NASH are major risk factors for other health conditions: more than 70% of patients are obese, up to 75% have type 2 diabetes, and anywhere from 20-80% have hyperlipidemia. Unchecked, NASH may lead to cirrhosis, liver cancer, and liver transplant.

Despite its prevalence and serious health consequences, NASH is relatively unknown. In a recent survey, only 6% of at-risk individuals had ever heard of NASH.

Against this backdrop, the first International NASH Day (IND) was launched on June 12, 2018, with the goal of raising awareness about NASH and the actions people can take to prevent the disease. Now under the Global Liver Institute’s leadership, International NASH Day is set to build off last year’s successes.

“We urge everyone to spread the word about NASH and its effects,” Donna Cryer, GLI’s President and Founder said. “Our goal is to shine light on this silent epidemic.”

"At Mayo Clinic and at Resoundant, we're committed to helping leaders like GLI in raising awareness globally," said Richard Ehman, MD, Radiologist at Mayo Clinic and CEO of Resoundant.

In dozens of international studies, MR Elastography has been found to be the most accurate non-invasive imaging exam for assessing liver fibrosis. It is recommended by a number of professional societies and in multidisciplinary clinical guidelines, including the American Gastroenterological Association and the American College of Radiology. To learn more about MRE for liver fibrosis assessment, visit www.resoundant.com/hepatology

For more information, visit www.international-nash-day.com.


+1 507-322-0011

© 2020 by Resoundant, Inc.

421 1st Ave SW STE 204W

Rochester, MN

55902, United States

  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon